Insulet Corporation has appointed Mike Panos as executive vice president and chief commercial officer to lead the firm’s global commercial organization. His expertise will help elevate Insulet's commercial capabilities as they accelerate growth.
Who to call at Insulet, and when
A new leader at Insulet brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Insulet raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Insulet, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Insulet. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Insulet
Location
100 Nagog Park
Acton, Massachusetts, United States
About
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is a medical device company simplifying life for people with diabetes through its Omnipod product platform. The tubeless, wearable Pod delivers up to three days of insulin without injections or fingersticks, with the Omnipod 5 system integrating with continuous glucose monitoring and smartphone control. Beyond diabetes, Insulet is also expanding its Omnipod technology to deliver other subcutaneous therapies.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Insulet changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
ActonBiotechnologyHealth CareMedicalMedical Devicemedical devices